...
首页> 外文期刊>Theriogenology >The regulatory role of icariin on apoptosis in mouse preimplantation embryos with reduced microRNA-21
【24h】

The regulatory role of icariin on apoptosis in mouse preimplantation embryos with reduced microRNA-21

机译:柠檬黄素对microRNA-21含量降低的小鼠植入前胚胎凋亡的调控作用

获取原文
获取原文并翻译 | 示例
           

摘要

We constructed a model of apoptosis in mouse preimplantation embryos and investigated the effect of the flavonol icariin on embryonic development in vitro in embryos with reduced microRNA-21 (miR-21). The model was generated by microinjecting an miR-21 inhibitor into the cytoplasm of mouse pronuclear embryos, which were cultured in vitro using modified CZB (mCZB) basal medium (model group), or using mCZB medium with 0.6 mu g/mL icariin as an experimental group (model-Ica). These were compared with embryos collected in vivo (vivo group) or not microinjected (control group). Developmental rates in vitro of two- and four-cell embryos and blastocysts were observed, and Hoechst 33342 and terminal deoxynucleotidyl transferase dUTP nick end labeling staining were used to count blastocyst cell numbers and apoptotic cell numbers and percentages. The transcriptional levels of miR-21, the apoptotic genes caspase 3 and phosphatase and tensin homolog deleted on chromosome ten (PTEN), and the antiapoptotic gene Bcl-2 were detected by quantitative polymerase chain reaction (qPCR). Western immunoblotting was used to detect the protein levels of caspase 3, PTEN, and Bcl-2. Compared with the model group, icariin treatment significantly improved blastocyst development in vitro (58.43 +/- 7.53% vs. 37.85 +/- 6.47%; P < 0.01), whereas it was not significantly different to the control group (60.34 +/- 9.86%). Icariin treatment significantly increased the blastocyst cell numbers (47.02 +/- 4.93 vs. 37.70 +/- 5.80; P < 0.01), and reduced the rates of apoptosis (5.51 +/- 2.35% vs. 10.11 +/- 4.21%; P < 0.01), whereas the blastocyst cell numbers and apoptotic rates revealed no significant differences between the vivo (46.06 +/- 6.50, 5.95 +/- 2.56%) and control groups (45.77 +/- 4.09, 6.18 +/- 2.41%). Icariin treatment significantly improved miR-21 expression in all embryo stages, reduced the transcriptional levels of caspase 3 and PTEN, and increased the levels of Bcl-2. The protein expression levels of caspase 3 and PTEN were decreased in blastocysts and the level of Bcl-2 was increased (P < 0.01). These had no significant differences with the vivo and control groups, and the protein levels revealed no significant differences between two- and four-cell embryos. Thus, miR-21 was necessary for preimplantation embryonic development, and embryo quality was closely associated with the apoptosis-related protein expression levels regulated by miR-21. Icariin upregulated miR-21 expression and reduced apoptosis in embryos with reduced miR-21. It also improved embryonic developmental quality in vitro, indicating an important regulatory role for miR-21 in blastocyst development in vitro.
机译:我们构建了小鼠植入前胚胎的细胞凋亡模型,并研究了黄酮甘菊酯对microRNA-21(miR-21)减少的胚胎体外胚胎发育的影响。该模型是通过将miR-21抑制剂微注射到小鼠原核胚胎的细胞质中而生成的,小鼠原核胚胎是使用改良的CZB(mCZB)基础培养基(模型组)或使用含有0.6μg / mL伞形素的mCZB培养基体外培养的实验组(Ica模型)。将它们与体内收集的胚胎(体内组)或未显微注射的胚胎(对照组)进行比较。观察到两细胞和四细胞胚胎和胚泡的体外发育速率,并使用Hoechst 33342和末端脱氧核苷酸转移酶dUTP缺口末端标记染色来计数胚泡细胞数,凋亡细胞数和百分数。通过定量聚合酶链反应(qPCR)检测miR-21的转录水平,凋亡基因caspase 3和磷酸酶以及张力蛋白同源物在第10号染色体(PTEN)上的缺失,以及抗凋亡基因Bcl-2。 Western免疫印迹用于检测caspase 3,PTEN和Bcl-2的蛋白水平。与模型组相比,icariin治疗显着改善了体外胚泡发育(58.43 +/- 7.53%vs. 37.85 +/- 6.47%; P <0.01),而与对照组无明显差异(60.34 +/- 9.86%)。鹰嘴豆素处理显着增加了胚泡细胞数量(47.02 +/- 4.93对37.70 +/- 5.80; P <0.01),并降低了凋亡率(5.51 +/- 2.35%对10.11 +/- 4.21%; P <0.01),而体内(46.06 +/- 6.50,5.95 +/- 2.56%)和对照组(45.77 +/- 4.09,6.18 +/- 2.41%)之间的胚泡细胞数和凋亡率无显着差异。鹰嘴豆素处理显着改善了所有胚胎阶段的miR-21表达,降低了caspase 3和PTEN的转录水平,并增加了Bcl-2的水平。胚泡中caspase 3和PTEN蛋白表达水平降低,Bcl-2水平升高(P <0.01)。这些与体内和对照组无显着差异,蛋白质水平显示两细胞和四细胞胚胎之间无显着差异。因此,miR-21是植入前胚胎发育所必需的,并且胚胎质量与miR-21调控的凋亡相关蛋白表达水平密切相关。伊卡瑞素上调miR-21降低胚胎中miR-21的表达并减少细胞凋亡。它还改善了体外胚胎发育质量,表明miR-21在体外胚泡发育中具有重要的调节作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号